The process of translating academic biomedical advances into clinical care improvements is difficult, risky, expensive, and poorly understood. Notably, many clinicians who identify health care problems do not have the time or expertise to solve the problems, and many academic researchers are unaware of important gaps in clinical care to which their expertise may apply.
Recognizing an opportunity to connect people who can identify health care problems with those who can solve them, the Yale Center for Biomedical Innovation and Technology (CBIT) was established in 2014 to educate and enhance the impact of health care innovators. The authors review other health care innovation centers (HICs), and describe best practices borrowed by Yale CBIT, which tailored its activities and approach to its unique ecosystem.
In four years, Yale CBIT has affected over 3,000 people and established a health care innovation cycle as an efficient strategy to guide translational research. Yale CBIT has created or supported graduate and undergraduate courses, clinical immersion programs for industry partners, and large health care hackathon events. Over 200 projects have been submitted to CBIT for mentorship, and some of those projects have been commercialized and raised millions of dollars of follow-on funding.
The authors present Yale CBIT as one model of accelerating the impact of academic medicine on clinical practice and outcomes. The project advising strategy is intended to be a template to maximize the efficiency of biomedical innovation and ultimately improve the outcomes and experiences of future patients.
A.L. Siefert is engineering director, Yale Center for Biomedical Innovation and Technology (CBIT), and biomedical engineering lecturer, Yale University, New Haven, Connecticut.
M.S. Cartiera is investment and innovation director, Yale CBIT and Center for Health Innovation, Yale New Haven Health System, New Haven, Connecticut.
A.N. Khalid is clinical director, Yale CBIT, New Haven, Connecticut; and clinical instructor, Harvard Medical School, Boston, Massachusetts.
M.C. Nantel is program coordinator, Yale CBIT, New Haven, Connecticut.
C.R. Loose is co-executive director, Yale CBIT, New Haven, Connecticut; and chief scientific officer, Frequency Therapeutics, Cambridge, Massachusetts.
P.G. Schulam is co-founder, Yale CBIT, chair of Urology, Yale School of Medicine, and faculty director, Tsai Center for Innovative Thinking, Yale University, New Haven, Connecticut.
W.M. Saltzman is co-founder, Yale CBIT, and Goizueta Foundation Professor of biomedical and chemical engineering, Yale University, New Haven, Connecticut.
M.K. Dempsey is co-executive director, Yale CBIT, New Haven, Connecticut; and entrepreneur-in-residence, Consortia for Improving Medicine with Innovation & Technology (CIMIT), Boston, Massachusetts.
Funding/Support: None reported.
Other disclosures: None reported.
Ethical approval: Reported as not applicable.
Previous presentations: The health care innovation framework was developed by Michael Dempsey, John Collins, John Parrish, Steve Schachter, and others at the Consortia for Improving Medicine with Innovation & Technology (CIMIT), used with permission.
Correspondence should be addressed to Michael Dempsey, 310 Cedar Street, BML 238B, New Haven, Connecticut, 06501; email: Michael.Dempsey@yale.edu.